Skip to main content
2026 MedCon Main banner

Lawrence Liberti

Director
D.K. Kim International Center for Regulatory Sciences at USC Officer

Dr. Liberti has worked in the fields of pharmaceutical regulatory affairs,
communications and clinical R&D for the past four decades. He began his
career at Wyeth Laboratories working in product development, then as a
regulatory writer in clinical R&D, and manager of safety surveillance in
medical affairs. For 11 years he served as the Executive Director of CIRS
(the Centre for Innovation in Regulatory Science) and then as Head of
Regulatory Collaborations. He began his role as the Director of the DK Kim
International Center for Regulatory Science in 2023. He has been actively
involved in promulgating best practices in the regulatory aspects of
medicines development and availability, especially in the emerging markets.
Dr Liberti received his doctorate in International Regulatory Policy through
the WHO Collaborating Centre for Pharmaceutical Policy and Regulation
based in the Utrecht Institute for Pharmaceutical Sciences, Utrecht
University, the Netherlands, where his research centered on expedited
regulatory pathways. He received both his Bachelor of Science in pharmacy
and Master’s degree in pharmacognosy from the Philadelphia College of
Pharmacy and Science. He was awarded an honorary Doctor of Science
degree by his alma mater. He attained the status of Regulatory Affairs
Certified (RAC) with the Regulatory Affairs Professional Society and serves on
its Board of Directors. He is a Fellow of the American Medical Writers
Association and is a recipient of their Golden Apple award for excellence in
teaching.

Presentation(s):